Eric E, Olupot-Olupot P, Bwayo D, Meya D, Katuramu R. Prevalence and factors associated with Cryptococcal antigenemia among patients with advanced human immunodeficiency virus in Eastern Uganda: A facility-based cross-sectional study. Open Forum Infect Dis. 2023;10(7). https://doi.org/10.1093/ofid/ofad351.

McKenney J, Bauman S, Neary B, Detels R, French A, Margolick J, et al. Prevalence, correlates, and outcomes of Cryptococcal antigen positivity among patients with AIDS, united States, 1986–2012. Clin Infect Dis. 2014;60(6):959–65. https://doi.org/10.1093/cid/ciu937.

Article  PubMed  PubMed Central  Google Scholar 

Osazuwa F, Dirisu JO, Okuonghae PE, Ugbebor O. Screening for Cryptococcal antigenemia in anti-retroviral Naïve AIDS patients in Benin City, Nigeria. Oman Med J. 2012;27(3):228–31. https://doi.org/10.5001/omj.2012.51.

Article  PubMed  PubMed Central  Google Scholar 

Oladele RO, Akanmu AS, Nwosu AO, Ogunsola FT, Richardson MD, Denning DW. Cryptococcal antigenemia in Nigerian patients with advanced human immunodeficiency virus: influence of antiretroviral therapy adherence. Open Forum Infect Dis. 2016;3(2). https://doi.org/10.1093/ofid/ofw055.

Oladele RO, Jordan AM, Okaa JU, Osaigbovo II, Shettima SA, Shehu NY, et al. A multicenter survey of asymptomatic Cryptococcal antigenemia among patients with advanced HIV disease in Nigeria. PLOS Glob Public Health. 2023;3(1):e0001313. https://doi.org/10.1371/journal.pgph.0001313.

Article  PubMed  PubMed Central  Google Scholar 

Wake RM, Molloy SF, Jarvis JN, Harrison TS, Govender NP. Cryptococcal antigenemia in advanced human immunodeficiency virus disease: pathophysiology, epidemiology, and clinical implications. Clin Infect Dis. 2022;76(4):764–70. https://doi.org/10.1093/cid/ciac675.

Article  PubMed Central  CAS  Google Scholar 

Ford N, Meintjes G, Calmy A, Bygrave H, Migone C, Vitoria M, et al. Managing advanced HIV disease in a public health approach. Clin Infect Dis. 2018;66(suppl2):S106–10. https://doi.org/10.1093/cid/cix1139.

Article  PubMed  PubMed Central  Google Scholar 

Geng EH, Nash D, Kambugu A, Zhang Y, Braitstein P, Christopoulos KA, et al. Retention in care among HIV-infected patients in resource-limited settings: emerging insights and new directions. Curr HIV/AIDS Rep. 2010;7(4):234–44. https://doi.org/10.1007/s11904-010-0061-5.

Article  PubMed  PubMed Central  Google Scholar 

Kharsany AB, Karim QA. HIV infection and AIDS in Sub-Saharan Africa: current status, challenges and opportunities. Open AIDS J. 2016;10:34–48. https://doi.org/10.2174/1874613601610010034.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Okwir M, Link A, Rhein J, Obbo JS, Okello J, Nabongo B, et al. High burden of Cryptococcal meningitis among antiretroviral therapy-experienced HIV-infected patients in Northern Uganda in the era of test and treat: implications for Cryptococcal screening programs. Open Forum Infect Dis. 2022;9(2):ofac004. https://doi.org/10.1093/ofid/ofac004.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Balogun O, Shuaib BI, Usman UA, Yusuf AA. Impact of viral load suppression on CD4 + T-cell count and BMI following combine antiretroviral therapy (cART) in HIV-1 infected individuals: preliminary findings in a resource poor setting. Anti-Infective Agents. 2022;20:e020622205560.

CAS  Google Scholar 

Usman A, Balogun O, Shuaib BI, Musa BOP, Yusuf AA, Ajayi EIO. Prevalence of cytopenia and its correlation with immunosuppression in Naïve HIV-1 infected patients initiating first-line antiretroviral therapy: a pilot study. Infect Chemother. 2023;55(4):479–89. https://doi.org/10.3947/ic.2023.0080.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Simon V, Ho DD, Karim QA. HIV/AIDS epidemiology, pathogenesis, prevention, and treatment. Lancet. 2006;368(9534):489–504. https://doi.org/10.1016/S0140-6736(06)69157-5.

Article  PubMed  PubMed Central  Google Scholar 

UNAIDS. (2021). Confronting Inequalities: Lessons for pandemic responses from 40 years of AIDS. https://www.unaids.org/en/resources/documents/2021/2021-global-aids-update

UNAIDS. (2020). Global HIV & AIDS statistics — 2020 fact sheet. https://www.unaids.org/en/resources/fact-sheet

Ford N, Migliori GB, Marks G, Raviglione M, Armstrong LR, Centis R, Horsburgh CR. The global burden of latent tuberculosis infection: A re-estimation using mathematical modelling. PLoS Med. 2018;15(10):e1002656. https://doi.org/10.1371/journal.pmed.1002656.

Article  Google Scholar 

World Health Organization (WHO). Guidelines for diagnosing, preventing and managing Cryptococcal disease among adults, adolescents and children living with HIV. Geneva: World Health Organization; 2022. https://www.ncbi.nlm.nih.gov/books/NBK581832/.

Google Scholar 

Geng EH, Nash D, Kambugu A, Zhang Y, Braitstein P, Christopoulos KA, Martin JN. Retention in care among HIV-infected patients in resource-limited settings: emerging insights and new directions. Curr HIV/AIDS Rep. 2010;7(4):234–44. https://doi.org/10.1007/s11904-010-0061-5.

Article  PubMed  PubMed Central  Google Scholar 

Mimicos EV, Fossaluza V, De Melo Picone C, De Sena CC, Gomes HR, Lázari CDS, et al. Prevalence and associated factors of Cryptococcal antigenemia in HIV-infected patients with CD4 < 200 cells/µl in São Paulo, Brazil: A bayesian analysis. J Fungi. 2022;8(12):1284. https://doi.org/10.3390/jof8121284.

Article  CAS  Google Scholar 

Dzoyem JP, Kechia FA, Ngaba GP, Lunga PK, Lohoue PJ. Prevalence of cryptococcosis among HIV-infected patients in Yaounde, Cameroon. Afr Health Sci. 2012;12(2):129–33.

PubMed  PubMed Central  CAS  Google Scholar 

Beyene T, Woldeamanuel Y, Asrat D, Ayana G, Boulware DR. Comparison of Cryptococcal antigenemia between antiretroviral Naive and antiretroviral experienced HIV positive patients at two hospitals in Ethiopia. PLoS ONE. 2013;8(10):e75585.

PubMed  PubMed Central  CAS  Google Scholar 

Abubakar AO, Maikai BV, Musa BO, Olayinka AT. Public health implications of Cryptococcal infection among HIV patients on antiretroviral therapy in hospital in Shika, Nigeria. Online J Public Health Inf. 2014;6:61–3.

Google Scholar 

Joseph G, Ogbaini–Emovon E, Okwara BU, Onunu A, Kubeyinje E. Prevalence of disseminated cryptococcosis among human immunodeficiency virus infected patients in Benin City, Nigeria. Br J Med Med Res. 2015;6(7):715–22.

Google Scholar 

Osazuwa OF, Dirisu O, Okunghae E. Cryptococcal antigenemia in anti–retroviral Naïve AIDS patients: prevalence and its association with CD4 cell count. Acta Med Iran. 2012;50(5):344–7.

PubMed  Google Scholar 

Ogba OM, Abia-Bassey L. Cryptococcal antigenemia among HIV seropositive patients accessing care in antiretroviral therapy (ART) clinics in Calabar, South Southern Nigeria. J Microbiol Infect. 2015;1:2.

Google Scholar 

Gomerep SS, Idoko JA, Ladep NG, Ugoya SO, Obaseki D, Agbaji OA, et al. Frequency of Cryptococcal meningitis in HIV1 infected patients in North central Nigeria. Niger J Med. 2010;19(4):395–9.

PubMed  CAS  Google Scholar 

Mamoojee Y, Shakoor S, Gorton RL, Sarfo S, Appiah LT, Norman B, et al. Low Seroprevalence of Cryptococcal antigenaemia in patients with advanced HIV infection enrolling in an antiretroviral programme in Ghana. Trop Med Int Health. 2011;16(1):53–6.

PubMed  Google Scholar 

Chukwuanukwu R, Manafa P, Iloghalu E, Onyenekwe C, Ifeanyichukwu M, Mbamalu C. Cryptococcus neoformans antigenemia in HIV positive pregnant women attending PMTCT clinic in South Eastern Nigeria. J Biol Agric Healthc. 2013;l3(18):15–21.

Google Scholar 

Minja M, Mbilinyi T, Mkinga B, Philipo EG, Owenya J, Kilonzi M. Prevalence, treatment, and factors associated with Cryptococcal meningitis post introduction of integrase inhibitors antiretroviral-based regimens among people living with HIV in Tanzania. PLoS ONE. 2024;19(2):e0294940. https://doi.org/10.1371/journal.pone.0294940.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Henao-Martínez AF, Gross L, Mcnair B, McCollister B, DeSanto K, Montoya JG, Shapiro L, Beckham JD. Risk factors for Cryptococcal meningitis: a single united States center experience. Mycopathologia. 2016;181(11–12):807–14. https://doi.org/10.1007/s11046-016-0048-x.

Article  PubMed  PubMed Central  Google Scholar 

World Health Organization. (2020). Guidelines for managing advanced HIV disease and rapid initiation of antiretroviral therapy. Geneva: World Health Organization. Available at: https://apps.who.int/iris/handle/10665/332294

Sadiq U, Shrestha U, Guzman N. Prevention of opportunistic infections in HIV/AIDS. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2023. Available from: https://www.ncbi.nlm.nih.gov/books/NBK513345

Warkentien T, Crum-Cianflone NF. An update on Cryptococcus among HIV-infected patients. Int J STD AIDS. 2010;21(10):679–84. https://doi.org/10.1258/ijsa.2010.010182.

Article  PubMed  PubMed Central  CAS  Google Scholar 

McHale TC, Boulware DR, Kasibante J, Ssebambulidde K, Skipper CP, Abassi M. Diagnosis and management of Cryptococcal meningitis in HIV-infected adults. Clin Microbiol Rev. 2023;36(4):e0015622. https://doi.org/10.1128/cmr.00156-22.

Article  PubMed  CAS  Google Scholar 

Kirkoyun Uysal H, Koksal MO, Sarsar K, Soguksu P, Erkose Genc G, Yapar G, Ozdemir E, Onel M, Mese S, Demirci M, Erturan Z, Yurtseven E, Eraksoy OH, Agacfidan A. Distribution of opportunistic pathogens in people living with HIV at a university hospital in Istanbul over a one-year treatment period and its association with CD4 T cell counts. Pathogens. 2023;12(10):1226. https://doi.org/10.3390/pathogens12101226.

Article  PubMed  PubMed Central